BioHealth News
WBJ: Johnson & Johnson’s D.C. incubator to leave Children’s National Hospital’s Walter Reed campus
By Sara Gilgore – Staff Reporter, Washington Business Journal - Johnson & Johnson Innovation’s D.C. incubator is preparing to leave Children’s National Hospital’s Research and Innovation…
Read More
Phlow Announces Close of $37M Series C Financing to Accelerate Modern Medicine Development and Manufacturing in America
Richmond, VA, July 22, 2025 (GLOBE NEWSWIRE) -- Phlow Corp., a leading American pharmaceutical contract development and manufacturing organization (CDMO), today announced the successful…
Read More
AstraZeneca plans to invest $50 billion in America for medicines manufacturing and R&D
AstraZeneca today announces $50 billion of investment in the United States by 2030, building on America’s global leadership in medicines manufacturing and R&D. This…
Read More
BioPharmaDive: Biotech startup funding dried up in second quarter, HSBC finds
7/17/2025 - Gwendolyn Wu - Even before HSBC’s report, there were signs of a biotech funding slowdown. Research the investment bank Jefferies published in May and again…
Read More
TEDCO Invests in Zero Point Five Therapeutics
COLUMBIA, Md., (July 21, 2025) — TEDCO, Maryland’s economic engine for technology companies, announced a recent Venture Funds investment for nearly $350,00 in Zero Point Five…
Read More
3 Days, 1 Region, Endless Opportunity: What to Expect at BHCR Week 2025
Planning is well underway for BioHealth Capital Region Week 2025, and hundreds of attendees have already registered for the Forum taking place September 23–25…
Read More
I-Mab Strengthens Givastomig Intellectual Property Portfolio through Acquisition of Bridge Health
ROCKVILLE, Md., July 17, 2025 (GLOBE NEWSWIRE) -- I-Mab (NASDAQ: IMAB) (the Company), a U.S.-based, global biotech company, focused on the development of precision…
Read More
60 Degrees Pharmaceuticals Announces Pricing of Up to $10 Million Public Offering
WASHINGTON, July 15, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (the “Company” or “60 Degrees”) (Nasdaq: SXTP; SXTPW), a pharmaceutical company focused on…
Read More
Gain Therapeutics Announces Proposed Public Offering
BETHESDA, Md., July 15, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery…
Read More
Cystic Fibrosis Foundation Commits Up to an Additional $24 Million for Prime Medicine to Develop Gene Editing Therapy
BETHESDA, Md.--(BUSINESS WIRE)--Today, the Cystic Fibrosis Foundation announced an additional investment of up to $24 million in Prime Medicine to continue the development of…
Read More
IonQ Completes Acquisition of Capella Space, Advancing Vision for Space-Based Quantum Communications
COLLEGE PARK, MD - July 15, 2025 - IonQ (NYSE: IONQ), a leading commercial quantum computing and networking company, today announced the completion of its…
Read More
UM School of Medicine Team Wins NIH TARGETED Challenge with Brain Genome Editing Technology
July 14, 2025 | Jon Kelvey - A team of researchers from the University of Maryland School of Medicine (UMSOM) recently won a $250,000 prize…
Read More
Now Enrolling: Maryland Global Consulting Program Relaunches This Fall
Maryland companies looking to expand their global reach can now apply for the Maryland Global Consulting Program, returning this fall with a new cohort…
Read More
Endpoint News: Biotech’s Q2 numbers paint a picture of the good, the bad and the ugly
By John Carroll, Editor & Founder - The numbers aren’t all bad in biotech. But you’d be forgiven if you thought they were. And you’d…
Read More
NSF advances 29 semifinalists in the second NSF Regional Innovation Engines competition
July 8, 2025 - The U.S. National Science Foundation Regional Innovation Engines (NSF Engines) program announced the 29 semifinalists advancing to the next stage of the second…
Read More